long term use tirzepatide Associated with Lower POAG, OHT Risk Compared with Other GLP-1 Drugs Is Tirzepatide Safe Long Term?

Are you making lifestyle changes during treatment that could help sustain results

By promoting weight loss, Trulicity can reduce the risk of obesity-related complications, such as heart disease

Therapeutic potential of the medicinal mushroom Ganoderma lucidum against Alzheimers disease

Food and Drug Administration (FDA) has approved its first oral glucagon-like peptide (GLP)-1 pill for weight management, a news release from Novo Nordisk announced on Monday

However, four injectable GLP-1 drugs, Saxenda (liraglutide), Wegovy (semaglutide), Bydureon BCISE (exenatide), and Trulicity (dulaglutide), have been approved for use in younger age groups

Phase 2 reported -24.2% body weight at 48 weeks at 12 mg, and Phase 3 TRIUMPH-4 reported up to -28.7% at 68 weeks at 12 mg